Publication: Oral direct anticoagulants in the treatment of nonvalvular atrial fibrillation. Results of the daily clinical practice.
| dc.contributor.author | Perez Villardon, B | |
| dc.contributor.author | Garcia Bellon, AM | |
| dc.contributor.author | Jimenez Rubio, C | |
| dc.contributor.author | Rubio Alcaide, A | |
| dc.contributor.author | Perez Benito, L | |
| dc.contributor.author | Ramirez Marrero, MA | |
| dc.contributor.author | De Mora Martin, M | |
| dc.contributor.author | De Teresa Galvan, E | |
| dc.contributor.authoraffiliation | [Perez Villardon,B; Jimenez Rubio,C; Rubio Alcaide,A; Perez Benito,L] Cardiology, Hospital Comarcal Axarquia, Velez-Malaga. [Garcia Bellon,AM; Ramirez Marrero,MA; De Mora Martin,M] Cardiology, Hospital Regional Carlos Haya. [De Teresa Galvan,E] Cardiology, Hospital Clinico Universitario Virgen de la Victoria, Malaga, Spain. | es |
| dc.date.accessioned | 2016-10-03T06:37:26Z | |
| dc.date.available | 2016-10-03T06:37:26Z | |
| dc.date.issued | 2016-06 | |
| dc.description.abstract | Atrial fibrillation (AF) is the most common arrhythmia. It leads to significant morbidity and mortality. The new oral anticoagulants (NOAC) represent an improvement compared with standard treatment (vitamin K antagonists (AVK)) in the prevention of thromboembolic complications in patients with non-valvular AF. | es |
| dc.description.version | No | es |
| dc.identifier.citation | Perez Villardon B; Garcia Bellon AM, Jimenez Rubio C; Rubio Alcaide A, Perez Benito L, Ramirez Marrero MA, et al. Oral direct anticoagulants in the treatment of nonvalvular atrial fibrillation. Results of the daily clinical practice. Haematologica. 2016; 101 (s1) P410, | es |
| dc.identifier.essn | 1592-8721 | |
| dc.identifier.issn | 0390-6078 | |
| dc.identifier.uri | http://hdl.handle.net/10668/2439 | |
| dc.journal.title | Haematologica | |
| dc.language.iso | en | |
| dc.organization | AGS Este de Málaga-Axarquía | |
| dc.publisher | Ferrata Storti Foundation | es |
| dc.relation.publisherversion | http://www.haematologica.org/content/101/s1 | es |
| dc.rights.accessRights | open access | |
| dc.subject | Anticoagulantes | es |
| dc.subject | Fibrilación atrial | es |
| dc.subject | Fibrinolíticos | es |
| dc.subject | Humanos | es |
| dc.subject | Vitamina K | es |
| dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Hematologic Agents::Anticoagulants | es |
| dc.subject.mesh | Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Arrhythmias, Cardiac::Atrial Fibrillation | es |
| dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Hematologic Agents::Fibrinolytic Agents | es |
| dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es |
| dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Polycyclic Compounds::Polycyclic Hydrocarbons, Aromatic::Naphthalenes::Naphthoquinones::Vitamin K | es |
| dc.title | Oral direct anticoagulants in the treatment of nonvalvular atrial fibrillation. Results of the daily clinical practice. | es |
| dc.type | conference presentation | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- PerezVillardonB_OralDirectAnticoagulants.pdf
- Size:
- 87.09 KB
- Format:
- Adobe Portable Document Format
- Description:
- Abstract